View Filing Data

(in thousands)

Balance at December 31, 2015

Adjustment to purchase price allocation of prior year acquisition

Effect of change in currency translation

Balance at September 30, 2016

Print Document View Excel Document

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2016	Oct. 28, 2016
Document And Entity Information [Abstract]
Document Type	10-Q
Document period end date	Sep. 30, 2016
Amendment flag	false
Document Period Focus	Q3
Document Fiscal Year Focus	2016
Current fiscal year end date	--12-31
Entity central index key	0001123494
Entity current reporting status	Yes
Entity filer category	Accelerated Filer
Entity registrant name	HARVARD BIOSCIENCE INC
Entity voluntary filers	No
Entity well known seasoned issuer	No
Entity common stock shares outstanding		34,374,345
Trading Symbol	HBIO

Statements of Financial Position - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current Assets:
Cash and cash equivalents	$ 5,345,000	$ 6,744,000
Accounts receivable, net of allowance for doubtful accounts of $386 and $310, respectively	15,115,000	17,547,000
Inventories	21,231,000	22,343,000
Deferred income tax assets - current	0	42,000
Other receivables and other assets	4,463,000	3,873,000
Total current assets	46,154,000	50,549,000
Property, plant and equipment, net	5,267,000	5,902,000
Deferred income tax assets - non-current	931,000	995,000
Amortizable intangible assets, net	18,861,000	20,872,000
Goodwill	39,624,000	40,357,000
Other indefinite lived intangible assets	1,227,000	1,223,000
Other assets	112,000	152,000
Total Assets	112,176,000	120,050,000
Current liabilities:
Current portion, long-term debt	2,374,000	2,364,000
Accounts payable	6,142,000	8,782,000
Deferred revenue	729,000	752,000
Accrued income taxes payable	218,000	290,000
Deferred income tax liabilities - current	0	2,246,000
Accrued expenses	4,501,000	4,021,000
Other liabilities - current	478,000	868,000
Total current liabilities	14,442,000	19,323,000
Long-term debt	12,668,000	16,369,000
Deferred income tax liabilities - non-current	6,532,000	3,775,000
Other liabilities- non current	2,643,000	2,985,000
Total liabilities	36,285,000	42,452,000
Stockholders Equity Abstract
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized	0	0
Common stock, par value $0.01 per share, 80,000,000 shares authorized; 42,119,852 and 41,724,772 shares issued and 34,374,345 and 33,979,265 shares outstanding, respectively	417,000	416,000
Additional paid-in-capital	214,132,000	211,457,000
Accumulated deficit	(114,710,000)	(111,723,000)
Accumulated other comprehensive loss	(13,280,000)	(11,884,000)
Treasury stock at cost, 7,745,507 common shares	(10,668,000)	(10,668,000)
Total stockholders' equity	75,891,000	77,598,000
Total liabilities and stockholders' equity	$ 112,176,000	$ 120,050,000

Statements of Financial Position (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
CONSOLIDATED BALANCE SHEETS
Allowance for doubtful accounts	$ 386	$ 310
Preferred Stock Par value	$ 0.01	$ 0.01
Preferred Stock - Shares Authorized	5,000,000	5,000,000
Common stock par value	$ 0.01	$ 0.01
Common Stock- Shares Authorized	80,000,000	80,000,000
Common Stock- Shares Issued	42,119,852	41,724,772
Common Stock- Shares Outstanding	34,374,345	33,979,265
Treasury Stock common shares	7,745,507	7,745,507

Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Statements of Operations - USD ($) $ in Thousands	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenues	$ 25,007	$ 25,731	$ 78,106	$ 80,294
Cost of revenues (exclusive of items shown separately below)	13,317	14,005	41,796	44,495
Gross profit	11,690	11,726	36,310	35,799
Sales and marketing expenses	5,006	5,028	15,194	15,355
General and administrative expenses	4,800	5,005	15,984	14,758
Research and development expenses	1,309	1,426	4,236	4,888
Restructuring charges (credits)	(17)	376	(5)	487
Amortization of intangible assets	729	666	2,099	2,137
Impairment charges	676	0	676	0
Total Operating Expenses	12,503	12,501	38,184	37,625
Operating income	(813)	(775)	(1,874)	(1,826)
Other (expense) income:
Foreign exchange	138	70	411	159
Interest expense	(142)	(204)	(486)	(641)
Interest income	1	1	2	5
Other income (expense), net	(64)	(188)	(143)	(984)
Other expense, net	(67)	(321)	(216)	(1,461)
Income from continuing operations before income taxes	(880)	(1,096)	(2,090)	(3,287)
Total Income Tax Expense	758	(249)	897	(1,388)
Net income (loss)	$ (1,638)	$ (847)	$ (2,987)	$ (1,899)
Earnings (loss) per share:
Basic earnings per common share	$ (0.05)	$ (0.02)	$ (0.09)	$ (0.06)
Diluted Earnings Per Common Share	$ (0.05)	$ (0.02)	$ (0.09)	$ (0.06)
Weighted average common shares:
Basic	34,327,459	33,933,327	34,156,606	33,473,958
Diluted	34,327,459	33,933,327	34,156,606	33,473,958
Consolidated Statements of Comprehensive Income [Abstract]
Net income (loss)	$ (1,638)	$ (847)	$ (2,987)	$ (1,899)
Foreign currency translation adjustments	(2,006)	(526)	(1,390)	(3,263)
Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease [Abstract]
Loss on derivative instruments designated and qualifying as cash flow hedges	11	(39)	(37)	(110)
Amounts reclassified from accumulated other comprehensive income to net income	(8)	(22)	(31)	(72)
Total Comprehensive Income (Loss), Net of Tax, total	$ (3,625)	$ (1,390)	$ (4,383)	$ (5,200)

Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
Statements of Cash Flows - USD ($) $ in Thousands	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net income (loss)	$ (2,987)	$ (1,899)
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	2,596	2,049
Depreciation	1,173	1,157
Impairment charges	676	0
(Gain) loss on sales of fixed assets	0	25
Non cash restructuring charge	(27)	(79)
Amortization Of Catalog Costs	13	8
Provision for allowance for doubtful accounts	59	3
Amortization of intangible assets	2,099	2,137
Amortization of deferred financing costs	72	58
Deferrred Income Taxes	455	(1,024)
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	2,145	754
Increase in inventories	735	(1,310)
Increase in other receivables and other assets	(742)	(407)
Increase in trade accounts payable	(2,785)	35
(Decrease) increase in accrued income taxes	(158)	(362)
Increase in accrued expenses	296	(2,046)
(Decrease) increase in deferred revenue	29	158
Increase (decrease) in other liabilities	7	(316)
Net cash provided by operating activities	3,656	(1,059)
Cash flows (used in) provided by investing activities:
Additions to property, plant and equipment	920	2,298
Additions to catalog costs	34	0
Proceeds from sales of property, plant and equipment	0	6
Acquisitions, net of cash acquired	0	(4,545)
Net cash used in investing activities	(954)	(6,837)
Cash flows provided by (used in) financing activities:
Repayments of debt	(6,738)	(6,100)
Net proceeds from issuance of debt	3,000	4,800
Payments of debt issuance costs	0	(32)
Net proceeds from issuance of common stock	80	1,953
Net cash (used in) provided by financing activities	(3,658)	621
Effect of exchange rate changes on cash	(443)	(769)
Increase in cash and cash equivalents	(1,399)	(8,044)
Cash and cash equivalents at the begining of period	6,744	14,134
Cash and cash equivalents at the end of period	5,345	6,090
Supplemental disclosures of cash flow information [Abstract]
Cash paid for interest	468	625
Cash paid for income taxes, net of refunds	$ 725	$ 625

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies Disclosure [Text Block]	HARVARD BIOSCIENCE, INC. NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS 1. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The unaudited consolidated financial statements of Harvard Bioscience, Inc. and its wholly-owned subsidiaries (collectively, “Harvard Bioscience” or the “Company”) as of September 30, 2016 and for the three and nine months ended September 30, 2016 and 2015 have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. The December 31, 2015 consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. However, the Company believes that the disclosures are adequate to make the information presented not misleading. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2015, which was filed with the SEC on April 29, 2016. In the opinion of management, all adjustments, which include normal recurring adjustments necessary to present a fair statement of financial position as of September 30, 2016, results of operations and comprehensive loss for the three and nine months ended September 30, 2016 and 2015 and cash flows for the nine months ended September 30, 2016 and 2015, as applicable, have been made. The results of operations for the three and nine months ended September 30, 2016 are not necessarily indicative of the operating results for the full fiscal year or any future periods. Summary of Significant Accounting Policies The accounting policies underlying the accompanying unaudited consolidated financial statements are those set forth in Note 2 to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, which was filed with the SEC on April 29, 2016.

Recently Issued Accounting Pronouncements	9 Months Ended
Recently Issued Accounting Pronouncements	Sep. 30, 2016
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements Disclosure [Text Block]	2. Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers,” a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in the United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. At its July 2015 meeting, the FASB agreed to defer the mandatory effective date of ASU 2014-09 one year. Under the one year deferral, the standard will take effect in 2018 for calendar year-end public entities. In July 2015, the FASB issued ASU 2015-11, Simplifying Measurement of Inventory. The update requires measurement of most inventory “at the lower of cost and net realizable value”, and applies to all entities that recognize inventory within the scope of ASC 330, except for inventory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. In February 2016, the FASB issued ASU 2016-02, Leases, which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. The update is effective for fiscal years beginning after December 15, 2018. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which simplifies the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The update is effective for fiscal years beginning after December 15, 2016 and early adoption is permitted. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of credit losses on Financial Instruments. The update amends the FASB’s guidance on the impairment of financial instruments. The ASU adds to U.S. GAAP an impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. The ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (Topic 230) which amends ASC 230,Statement of Cash Flows to add or clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is evaluating the impact of each of ASU 2014-09, ASU 2015-11, ASU 2016-02, ASU 2016-09, ASU 2016-13 and ASU 2016-15 on its consolidated financial statements. Recently Adopted Accounting Pronouncements In April 2015, the FASB issued ASU 2015-03, Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs. Under this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance during the nine months ended September 30, 2016. The consolidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such costs as a direct deduction from the debt liability on the consolidated balance sheet. In September 2015, the FASB issued ASU 2015-16, Simplifying the Accounting for Measurement-Period Adjustments. The update eliminates the requirement to retrospectively adjust financial statements for measurement-period adjustments that occur in periods after a business combination. Under the update, measurement-period adjustments are to be calculated as if they were known at the acquisition date, but are recognized in the reporting period in which they are determined. Additional disclosures are required about the impact on current-period earnings. ASU 2015-16 requires prospective application to adjustments of provisional amounts that occur after the effective date. The update was effective for fiscal years beginning after December 15, 2015. The Company adopted ASU 2015-16 on January 1, 2016. The adoption of ASU 2015-16 did not have a material impact on its consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to classify deferred taxes between current and noncurrent. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted at the beginning of an interim or annual period. During the nine months ended September 30, 2016, the Company early adopted the new guidance on a prospective basis and has presented all deferred tax assets and deferred tax liabilities as noncurrent in the consolidated balance sheet at September 30, 2016.

Accumulated Other Comprehensive Income

9 Months Ended

Sep. 30, 2016

Accumulated Other Comprehensive Income [Abstract]

Accumulated Other Comprehensive Income Disclosure [Text Block]

3. Accumulated Other Comprehensive Loss

Changes in each component of accumulated other comprehensive loss, net of tax are as follows:

		Foreign currency		Derivatives
		translation		qualifying as		Defined benefit
(in thousands)		adjustments		hedges		pension plans		Total

Balance at December 31, 2015	$	(9,594)	$	(10)	$	(2,280)	$	(11,884)

Other comprehensive loss before reclassifications		(1,390)		(37)		-		(1,427)
Amounts reclassified from AOCI		-		31		-		31

Other comprehensive loss		(1,390)		(6)		-		(1,396)

Balance at September 30, 2016	$	(10,984)	$	(16)	$	(2,280)	$	(13,280)

- Definition

The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

Acquisitions

9 Months Ended

Sep. 30, 2016

Acquisition Disclosure [Abstract]

Acquisitions Disclosure [Text Block]

4. Acquisitions

The Company completed one acquisition during the nine months ended September 30, 2015.

HEKA Elektronik

On January 8, 2015, the Company, through its wholly-owned Ealing Scientific Limited and Multi Channel Systems MCS GmbH (“MCS”) subsidiaries, acquired all of the issued and outstanding shares of HEKA Elektronik (“HEKA”) for approximately $5.9 million, or $4.5 million, net of cash acquired. Included in the acquisition of HEKA were: HEKA Electronik Dr. Schulze GmbH, based in Lambrecht, Germany (“HEKA Germany”); HEKA Electronics Incorporated, based in Chester, Nova Scotia, Canada (“HEKA Canada”); and HEKA Instruments Incorporated, based in Bellmore, New York. The Company funded the acquisition from its existing cash balances.

HEKA is a developer, manufacturer and marketer of sophisticated electrophysiology instrumentation and software for biomedical and industrial research applications. This acquisition is complementary to the electrophysiology line currently offered by the Company’s wholly-owned Warner Instruments and MCS subsidiaries.

The aggregate purchase price for this acquisition was allocated to tangible and intangible assets acquired as follows:

		(in thousands)
Tangible assets	$	4,165
Liabilities assumed		(2,426)
Net assets		1,739

Goodwill and intangible assets:
Goodwill		1,668
Trade name		774
Customer relationships		1,627
Developed technology		1,338
Non-compete agreements		27
Deferred tax liabilities		(1,245)
Total goodwill and intangible assets, net of tax		4,189
Acquisition purchase price	$	5,928

Goodwill recorded as a result of the acquisition of HEKA is not deductible for tax purposes.

In the second quarter of 2016, an immaterial correction was made to the allocation of the aggregate purchase price to the tangible and intangible assets acquired to increase both accrued liabilities and goodwill by $50,000 as of June 30, 2016. This correction has been reflected in the table above.

The results of operations for HEKA have been included in the Company’s consolidated financial statements from the date of acquisition.

Direct acquisition costs recorded in other expense, net in the Company’s consolidated statements of operations were immaterial for both the three and nine months ended September 30, 2016, respectively. Direct acquisition costs recorded in other expense, net in the Company’s consolidated statements of operations were $0.2 million and $0.9 million for the three and nine months ended September 30, 2015, respectively.

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

Goodwill and Other Intangible Assets

9 Months Ended

Sep. 30, 2016

Goodwill And Other Intangible Assets Disclosure [Abstract]

Goodwill And Other Intangible Assets Disclosure [Text Block]

5. Goodwill and Other Intangible Assets

Intangible assets consist of the following:

									Weighted
									Average
		September 30, 2016				December 31, 2015			Life	(a)
		(in thousands)
Amortizable intangible assets:		Gross		Accumulated Amortization		Gross		Accumulated Amortization
Existing technology	$	15,687	$	(11,962)	$	16,022	$	(11,686)	7.1	Years
Trade names		7,623		(3,440)		7,636		(3,076)	8.2	Years
Distribution agreements/customer relationships		23,653		(12,800)		23,676		(11,849)	9.1	Years
Patents		216		(116)		245		(96)	2.4	Years
Total amortizable intangible assets		47,179	$	(28,318)		47,579	$	(26,707)

Indefinite-lived intangible assets:
Goodwill		39,624				40,357
Other indefinite-lived intangible assets		1,227				1,223
Total goodwill and other indefinite-lived intangible assets		40,851				41,580

Total intangible assets, gross	$	88,030			$	89,159

(a) Weighted average life as of September 30, 2016.

The change in the carrying amount of goodwill for the nine months ended September 30, 2016 is as follows:

Impairment of intangible assets

During the third quarter of 2016, the Company initiated plans to sell the operations of its AHN Biotechnologie GmbH subsidiary (“AHN”), a manufacturer of liquid handling products, located in Nordhausen, Germany. The Company assessed the held for sale accounting guidance, pursuant to ASC 360-10, and concluded that it had not met all the criteria for AHN’s assets and liabilities to be classified as held for sale as of September 30, 2016. As such, AHN’s assets and liabilities continue to be presented as held and used, and the results of its operations included within continuing operations as of, and for the three and nine months ended September 30, 2016, respectively.

As a result of the Company initiating plans to sell the operations of AHN, the Company evaluated the long-lived assets for impairment, pursuant to ASC 360-10. Based on the impairment analysis, the carrying amount of the long-lived assets exceeded the fair value of the long-lived assets as determined using the probability weighted present value of future cash flows. As a result, the Company recognized an impairment charge of $0.7 million for the three and nine months ended September 30, 2016 as part of operating expenses within its statements of operations. Of the overall charge, approximately $0.1 million was allocated to its intangible assets (trade name and customer relationships), while the remainder of the charge was allocated to its property, plant and equipment (machinery and equipment).

As also noted in footnote 18, on October 26, 2016, the Company sold AHN for $1.7 million in cash proceeds.

Amortization of intangible assets

Intangible asset amortization expense was $0.7 million for both the three months ended September 30, 2016 and 2015. Intangible asset amortization expense was $2.1 million for both the nine months ended September 30, 2016 and 2015. Amortization expense of existing amortizable intangible assets is currently estimated to be $2.6 million for the year ending December 31, 2016, $2.5 million for the year ending December 31, 2017, $2.3 million for the year ending December 31, 2018, $2.2 million for the year ending December 31, 2019 and $2.1 million for the year ending December 31, 2020.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

Inventories

9 Months Ended

Sep. 30, 2016

Inventories Disclosure [Abstract]

Inventories Disclosure [Text Block]

6. Inventories

Inventories consist of the following:

			September 30,		December 31,
			2016		2015
			(in thousands)
Finished goods		$	9,465	$	10,957
Work in process			935		888
Raw materials			10,831		10,498
	Total	$	21,231	$	22,343

Property, Plant and Equipment

9 Months Ended

Sep. 30, 2016

Property, Plant and Equipment Disclosure [Abstract]

Property, Plant and Equipment Disclosure [Text Block]

7. Property, Plant and Equipment

As disclosed in footnote 5, as a result of its decision to initiate a plan to sell the operations of AHN, during the third quarter of 2016 the Company recorded an impairment charge to property, plant and equipment of $0.6 million.

As of September 30, 2016 and 2015, property, plant and equipment consist of the following:

		September 30,		December 31,
		2016		2015
		(in thousands)
Land, buildings and leasehold improvements	$	2,594	$	2,825
Machinery and equipment		9,590		10,131
Computer equipment and software		7,989		7,503
Furniture and fixtures		1,590		1,358
Automobiles		221		103
		21,984		21,920
Less: accumulated depreciation		(16,717)		(16,018)
Property, plant and equipment, net	$	5,267	$	5,902

Restructuring and Other Exit Costs

9 Months Ended

Sep. 30, 2016

Restructuring and Related Activities [Abstract]

Restructuring And Other Exit Costs Disclosure [Text Block]

8. Restructuring and Other Exit Costs

During 2014, and 2015, the Company entered into various restructuring plans, which included eliminating certain positions made redundant as a result of its site consolidations, as well as a realignment of its commercial sales team. The 2014 restructuring plan included plans to relocate the distribution operations of the Company’s Denville Scientific subsidiary from New Jersey to North Carolina, as well as consolidating the manufacturing operations of its Biochrom subsidiary to its headquarters in Holliston, MA. Activity and liability balances related to these charges during the current year were as follows:


		Severance Costs		Other		Total
		(in thousands)
Restructuring balance at December 31, 2015	$	132	$	-	$	132
Restructuring charges		-		32		32
Non-cash reversal of restructuring charges		(27)		-		(27)
Cash payments		(101)		(28)		(129)
Effect of change in currency translation		(4)		(4)		(8)
Restructuring balance at September 30, 2016	$	-	$	-	$	-

		Severance Costs		Other		Total
		(in thousands)
Restructuring balance at December 31, 2014	$	626	$	-	$	626
Restructuring charges		227		339		566
Non-cash reversal of restructuring charges		(79)		-		(79)
Cash payments		(650)		(295)		(945)
Effect of change in currency translation		(8)		-		(8)
Restructuring balance at September 30, 2015	$	116	$	44	$	160

Aggregate net restructuring charges for the three and nine months ended September 30, 2016 and 2015 were as follows:

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015
		(in thousands)
Restructuring charges	$	(17)	$	376	$	(5)	$	487

Related Party Transactions	9 Months Ended
Related Party Transactions	Sep. 30, 2016
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	9. Related Party Transactions As part of the acquisitions of MCS and Triangle BioSystems, Inc. (“TBSI”) in 2014, the Company signed lease agreements with the former owners of the acquired companies. The principals of such former owners of MCS and TBSI were employees of the Company as of September 30, 2016 and 2015. Pursuant to a lease agreement, the Company incurred rent expense of approximately $59,000 and $172,000 to the former owners of MCS for both the three and nine months ended September 30, 2016 and September 30, 2015, respectively. The Company incurred rent expense of approximately $11,000 and $32,000 to the former owners of TBSI for both the three and nine months ended September 30, 2016 and September 30, 2015, respectively.

- Definition

The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.

+ References + Details

Warranties

9 Months Ended

Sep. 30, 2016

Warranties Disclosure [Abstract]

Warranties Disclosure [Text Block]

10. Warranties

Warranties are estimated and accrued at the time revenues are recorded. A rollforward of the Company’s product warranty accrual is as follows:

		Beginning		Additions/		Ending
		Balance	Payments	(Credits)		Balance
		(in thousands)

Year ended December 31, 2015	$	252	(81)	(24)	$	147

Nine months ended September 30, 2016	$	147	(56)	94	$	185

Employee Benefit Plans

9 Months Ended

Sep. 30, 2016

Employee Benefit Plans Disclosure [Abstract]

Employee Benefit Plans Disclosure [Text Block]

11. Employee Benefit Plans

Certain of the Company’s subsidiaries in the United Kingdom, or UK, Harvard Apparatus Limited and Biochrom Limited, maintain contributory, defined benefit or defined contribution pension plans for substantially all of their employees. These defined benefit pension plans are closed to new employees, as well as closed to the future accrual of benefits for existing employees. The components of the Company’s defined benefit pension expense were as follows:

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015
		(in thousands)
Components of net periodic benefit cost:
Interest cost	$	156	$	175	$	492	$	542
Expected return on plan assets		(168)		(165)		(530)		(510)
Net amortization loss		74		75		233		231
Net periodic benefit cost	$	62	$	85	$	195	$	263

For the three months ended September 30, 2016 and 2015, the Company contributed $0.2 million, for both periods, to its defined benefit pension plans. For the nine months ended September 30, 2016 and 2015, the Company contributed $0.5 million and $0.6 million, respectively, to its defined benefit pension plans. The Company expects to contribute approximately $0.3 million to its defined benefit pension plans during the remainder of 2016.

The Company had an underfunded pension liability of approximately $2.5 million and $2.8 million, as of September 30, 2016 and December 31, 2015, respectively, included in the other long term liabilities line item in the consolidated balance sheets.

Leases

9 Months Ended

Sep. 30, 2016

Leases Disclosure [Abstract]

Leases Disclosure [Text Block]

12. Leases

The Company has noncancelable operating leases for office and warehouse space expiring at various dates through 2021 and thereafter. Rent expense, which is recorded on a straight-line basis, is estimated to be $1.9 million for the year ended December 31, 2016. Rent expense was approximately $0.5 million and $0.6 million for the three months ended September 30, 2016 and 2015, respectively. Rent expense was approximately $1.4 million and $1.8 million for the nine months ended September 30, 2016 and 2015, respectively.

Future minimum lease payments for operating leases, with initial or remaining terms in excess of one year at September 30, 2016, are as follows:

		Operating
		Leases
		(in thousands)
2017	$	1,754
2018		1,754
2019		1,647
2020		1,423
2021		1,216
Thereafter		3,372
Net minimum lease payments	$	11,166

- Definition

Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions. Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.

+ References + Details

Capital Stock

9 Months Ended

Sep. 30, 2016

Capital Stock Disclosure [Abstract]

Capital Stock Disclosure [Text Block]

13. Capital Stock

Common Stock

On February 5, 2008, the Company’s Board of Directors adopted a Shareholder Rights Plan and declared a dividend distribution of one preferred stock purchase right for each outstanding share of the Company’s common stock to shareholders of record as of the close of business on February 6, 2008. Initially, these rights will not be exercisable and will trade with the shares of the Company’s common stock. Under the Shareholder Rights Plan, the rights generally will become exercisable if a person becomes an “acquiring person” by acquiring 20% or more of the common stock of the Company or if a person commences a tender offer that could result in that person owning 20% or more of the common stock of the Company. If a person becomes an acquiring person, each holder of a right (other than the acquiring person) would be entitled to purchase, at the then-current exercise price, such number of shares of preferred stock which are equivalent to shares of the Company’s common stock having a value of twice the exercise price of the right. If the Company is acquired in a merger or other business combination transaction after any such event, each holder of a right would then be entitled to purchase, at the then-current exercise price, shares of the acquiring company’s common stock having a value of twice the exercise price of the right.

Preferred Stock

The Company’s Board of Directors has the authority to issue up to 5.0 million shares of preferred stock and to determine the price privileges and other terms of the shares. The Board of Directors may exercise this authority without any further approval of stockholders. As of September 30, 2016, the Company had no preferred stock issued or outstanding.

Employee Stock Purchase Plan (as amended, the “ESPP”)

In 2000, the Company approved the ESPP. Under this ESPP, participating employees can authorize the Company to withhold a portion of their base pay during consecutive six-month payment periods for the purchase of shares of the Company’s common stock. At the conclusion of the period, participating employees can purchase shares of the Company’s common stock at 85% of the lower of the fair market value of the Company’s common stock at the beginning or end of the period. Shares are issued under the ESPP for the six-month periods ending June 30 and December 31. Under this plan, 750,000 shares of common stock are authorized for issuance of which 683,364 shares were issued as of September 30, 2016. During the nine months ended September 30, 2016 and 2015, the Company issued 39,353 shares and 26,181 shares, respectively, of the Company’s common stock under the ESPP. There were no shares issued under the ESPP during the three months ended September 30, 2016 and 2015.

Stock Option and Equity Incentive Plans

Third Amended and Restated 2000 Stock Option and Incentive Plan (as amended, the “Third A&R Plan”)

The Second Amendment to the Third A&R Plan (the “Amendment”) was adopted by the Board of Directors on April 3, 2015. Such Amendment was approved by the stockholders at the Company’s 2015 Annual Meeting of Stockholders. Pursuant to the Amendment, the aggregate number of shares authorized for issuance under the Third A&R Plan was increased by 2,500,000 shares to 17,508,929.

Restricted Stock Units with a Market Condition (the “Market Condition RSU’s”)

On August 3, 2015, the Compensation Committee of the Board of Directors of the Company approved and granted deferred stock awards of Market Condition RSU’s to certain members of the Company’s management team under the Third A&R Plan. The vesting of these Market Condition RSU’s is cliff-based and linked to the achievement of a relative total shareholder return of the Company’s common stock from August 3, 2015 to the earlier of (i) August 3, 2018 or (ii) upon a change of control (measured relative to the Russell 3000 index and based on the 20-day trading average price before each such date). As of September 30, 2016, the target number of these restricted stock units that may be earned is 182,150 shares; the maximum amount is 150% of the target number.

Stock-Based Payment Awards

The Company accounts for stock-based payment awards in accordance with the provisions of FASB ASC 718, which requires it to recognize compensation expense for all stock-based payment awards made to employees and directors including stock options, restricted stock units, Market Condition RSU’s and employee stock purchases related to the ESPP.

Stock option and restricted stock unit activity under the Company’s Third A&R Plan for the nine months ended September 30, 2016 was as follows:

		Stock Options			Restricted Stock Units			Market Condition RSU's
				Weighted
		Stock		Average	Restricted			Market
		Options		Exercise	Stock Units		Grant Date	Condition RSU's		Grant Date
		Outstanding		Price	Outstanding		Fair Value	Outstanding		Fair Value

Balance at December 31, 2015		5,022,186	$	3.85	313,559	$	5.29	185,538	$	4.81
	Granted	43,000		3.10	1,095,190		2.92	-		-
	Exercised	(374,772)		2.80	-		-	-		-
	Vested (RSUs)	-		-	(276,420)		-	-		-
	Cancelled / forfeited	(672,166)		3.87	(31,782)		3.87	(3,388)		4.81
Balance at September 30, 2016		4,018,248	$	3.97	1,100,547	$	3.15	182,150	$	4.81

The weighted average fair value of the options granted under the Third A&R Plan during the three months ended September 30, 2016 and 2015 was $1.11 and $2.14, respectively. The weighted average fair value of the options granted under the Third A&R Plan during the nine months ended September 30, 2016 and 2015 was $1.21 and $2.21, respectively. The following assumptions were used to estimate the fair value, using the Black-Scholes option pricing model, of stock options granted during the three and nine months ended September 30, 2016 and 2015:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2016		2015		2016		2015
Volatility	43.05	%	39.47	%	41.97	%	41.07	%
Risk-free interest rate	1.01	%	1.76	%	1.29	%	1.72	%
Expected holding period (in years)	5.08	years	5.25	years	5.21	years	5.52	years
Dividend yield	-	%	-	%	-	%	-	%

The weighted average fair value of the Market Condition RSU’s granted under the Third A&R Plan during the three months ended September 30, 2015 was $4.81. The following assumptions were used to estimate the fair value, using a Monte-Carlo valuation simulation, of the Market Condition RSU’s granted during the three months ended September 30, 2015:

	Three Months Ended
	September 30,
	2015
Volatility	35.88	%
Risk-free interest rate	0.99	%
Correlation coefficient	0.25	%
Dividend yield	-	%

The Company used historical volatility to calculate the expected volatility for each grant as of the grant date. Historical volatility was determined by calculating the mean reversion of the daily adjusted closing stock price. The risk-free interest rate assumption is based upon observed U.S. Treasury bill interest rates (risk-free) appropriate for the term of the Company’s stock options and Market Condition RSU’s. The expected holding period of stock options represents the period of time options are expected to be outstanding and is based on historical experience. The vesting period ranges from one to four years and the contractual life is ten years. The correlation coefficient, used to value the Market Condition RSU’s, represents the way in which entities move in relation to the Russell 3000 index as a whole.

Stock-based compensation expense related to stock options, restricted stock units, Market Condition RSU’s and the ESPP for the three and nine months ended September 30, 2016 and 2015 was allocated as follows:

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015
		(in thousands)

Cost of revenues	$	17	$	18	$	44	$	54
Sales and marketing		159		149		401		343
General and administrative		736		583		2,071		1,580
Research and development		31		27		80		72
Total stock-based compensation	$	943	$	777	$	2,596	$	2,049

The Company did not capitalize any stock-based compensation.

Earnings per share

Basic earnings per share is based upon net income divided by the number of weighted average common shares outstanding during the period. The calculation of diluted earnings per share assumes conversion of stock options, restricted stock units and Market Condition RSU’s into common stock using the treasury method. The weighted average number of shares used to compute basic and diluted earnings per share consists of the following:

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2016	2015	2016	2015

Basic	34,327,459	33,933,327	34,156,606	33,473,958
Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU's	-	-	-	-
Diluted	34,327,459	33,933,327	34,156,606	33,473,958

Excluded from the shares used in calculating the diluted earnings per common share in the above table are options, restricted stock units and Market Condition RSU’s of approximately 5,300,945 and 5,640,536 shares of common stock for the three and nine months ended September 30, 2016 and 2015, respectively, as the impact of these shares would be anti-dilutive.

Long Term Debt

9 Months Ended

Sep. 30, 2016

Long Term Debt Disclosure [Abstract]

Long Term Debt Disclosure [Text Block]

14. Long Term Debt

On August 7, 2009, the Company entered into an Amended and Restated Revolving Credit Loan Agreement related to a $20.0 million revolving credit facility with Bank of America, as agent, and Bank of America and Brown Brothers Harriman & Co as lenders (as amended, the “2009 Credit Agreement”). Between September 2011, and June 2016, the Company entered into six amendments that among other things extended the maturity date of the credit facility; reduced interest rates; converted existing loan advances into a term loan in the principal amount of $15.0 million (the “Term Loan”); provided a revolving credit facility in the maximum principal amount of $25.0 million (“Revolving Line”); provided a delayed draw term loan of up to $10.0 million (the “DDTL”); amended the principal payment amortization of the Term Loan and DDTL to five years, as well as amended the Company’s quarterly minimum fixed charge coverage financial covenant.

The maximum amount available under the Credit Agreement is $50.0 million as borrowings against the DDTL in excess of $10.0 million results in a dollar for dollar reduction in the Revolving Line capacity. The Revolving Line, Term Loan and DDTL each have a maturity date of March 29, 2018. Borrowings under the Term Loan and the DDTL accrue interest at a rate based on either the effective London Interbank Offered Rate (LIBOR) for certain interest periods selected by the Company, or a daily floating rate based on the British Bankers’ Association (BBA) LIBOR as published by Reuters (or other commercially available source providing quotations of BBA LIBOR), plus in either case, a margin of 2.75%. Additionally, the Revolving Line accrues interest at a rate based on either the effective LIBOR for certain interest periods selected by the Company, or a daily floating rate based on the BBA LIBOR, plus in either case, a margin of 2.25%. The Company was required to fix the rate of interest on at least 50% of the Term Loan and the DDTL through the purchase of interest rate swaps.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs. Under this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance during the nine months ended September 30, 2016. The consolidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such costs as a direct deduction from the debt liability on the consolidated balance sheet.

As of September 30, 2016 and December 31, 2015, the Company had net borrowings of $15.0 million and $18.7 million, respectively, outstanding under its Credit Agreement. As of September 30, 2016, the Company was in compliance with all financial covenants contained in the Credit Agreement, was subject to covenant and working capital borrowing restrictions and had available borrowing capacity under its Credit Agreement of $7.8 million.

As of September 30, 2016, the weighted effective interest rates, net of the impact of the Company’s interest rate swaps, on its Term Loan, DDTL and Revolving Line borrowings were 3.96%, 3.60% and 2.77%, respectively.

As of September 30, 2016 and December 31, 2015, the Company’s borrowings were comprised of:

		September 30,		December 31,
		2016		2015
		(in thousands)
Long-term debt:
Term loan	$	5,737	$	6,750
DDTL		4,675		5,500
Revolving line		4,750		6,650
Total unamortized deferred financing costs		(120)		(167)
Total debt		15,042		18,733
Less: current installments		(2,450)		(2,450)
Current unamortized deferred financing costs		76		86
Long-term debt	$	12,668	$	16,369

Derivatives

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities Disclosure [Text Block]

15. Derivatives

The Company uses interest-rate-related derivative instruments to manage its exposure related to changes in interest rates on its variable-rate debt instruments. The Company does not enter into derivative instruments for any purpose other than cash flow hedging. The Company does not speculate using derivative instruments.

By using derivative financial instruments to hedge exposures to changes in interest rates, the Company exposes itself to credit risk and market risk. Credit risk is the failure of the counterparty to perform under the terms of the derivative contract. When the fair value of a derivative contract is positive, the counterparty owes the Company, which creates credit risk for the Company. When the fair value of a derivative contract is negative, the Company owes the counterparty and, therefore, the Company is not exposed to the counterparty’s credit risk in those circumstances. The Company minimizes counterparty credit risk in derivative instruments by entering into transactions with carefully selected major financial institutions based upon their credit profile.

Market risk is the adverse effect on the value of a derivative instrument that results from a change in interest rates. The market risk associated with interest-rate contracts is managed by establishing and monitoring parameters that limit the types and degree of market risk that may be undertaken.

The Company assesses interest rate risk by continually identifying and monitoring changes in interest rate exposures that may adversely impact expected future cash flows and by evaluating hedging opportunities. The Company maintains risk management control systems to monitor interest rate risk attributable to both the Company’s outstanding or forecasted debt obligations as well as the Company’s offsetting hedge positions. The risk management control systems involve the use of analytical techniques, including cash flow sensitivity analysis, to estimate the expected impact of changes in interest rates on the Company’s future cash flows.

The Company uses variable-rate London Interbank Offered Rate (LIBOR) debt to finance its operations. The debt obligations expose the Company to variability in interest payments due to changes in interest rates. Management believes that it is prudent to limit the variability of a portion of its interest payments. To meet this objective, management enters into LIBOR based interest rate swap agreements to manage fluctuations in cash flows resulting from changes in the benchmark interest rate of LIBOR. These swaps change the variable-rate cash flow exposure on the debt obligations to fixed cash flows. Under the terms of the interest rate swaps, the Company receives LIBOR based variable interest rate payments and makes fixed interest rate payments, thereby creating the equivalent of fixed-rate debt for the notional amount of its debt hedged. In accordance with its Credit Agreement, the Company was required to fix the rate of interest on at least 50% of its Term Loan and the DDTL through the purchase of interest rate swaps. On June 5, 2013, the Company entered into an interest rate swap contract with an original notional amount of $15.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in the effective benchmark interest rate (LIBOR) associated with the Company’s Term Loan. On November 29, 2013, the Company entered into a second interest rate swap contract with an original notional amount of $5.0 million and a maturity date of March 29, 2018 in order to hedge the risk of changes in the effective benchmark interest rate (LIBOR) associated with the DDTL. The notional amount of the Company’s derivative instruments as of September 30, 2016 was $6.5 million. The Term Loan swap contract effectively converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at 0.96% plus a bank margin of 2.75%. The DDTL swap contract effectively converted specific variable-rate debt into fixed-rate debt and fixed the LIBOR rate associated with the Term Loan at 0.93% plus a bank margin of 2.75%.The interest rate swaps were designated as cash flow hedges in accordance with ASC 815, Derivatives and Hedging.

The following table presents the notional amount and fair value of the Company’s derivative instruments as of September 30, 2016 and December 31, 2015.


				September 30, 2016		September 30, 2016
				Notional Amount		Fair Value (a)
Derivatives designated as hedging instruments under ASC 815		Balance sheet classification		(in thousands)
Interest rate swaps		Other liabilities-non current	$	6,500	$	(16)


				December 31, 2015		December 31, 2015
				Notional Amount		Fair Value (a)
Derivatives designated as hedging instruments under ASC 815		Balance sheet classification		(in thousands)
Interest rate swaps		Other liabilities-non current	$	9,500	$	(10)

	(a) See Note 16 for the fair value measurements related to these financial instruments.

All of the Company’s derivative instruments are designated as hedging instruments.

The Company has structured its interest rate swap agreements to be 100% effective and as a result, there was no impact to earnings resulting from hedge ineffectiveness. Changes in the fair value of interest rate swaps designated as hedging instruments that effectively offset the variability of cash flows associated with variable-rate, long-term debt obligations are reported in accumulated other comprehensive income (“AOCI”). These amounts subsequently are reclassified into interest expense as a yield adjustment of the hedged interest payments in the same period in which the related interest affects earnings. The Company’s interest rate swap agreement was deemed to be fully effective in accordance with ASC 815, and, as such, unrealized gains and losses related to these derivatives were recorded as AOCI.

The following table summarizes the effect of derivatives designated as cash flow hedging instruments and their classification within comprehensive loss for the three and nine months ended September 30, 2016 and 2015:

Derivatives in Hedging Relationships	Amount of gain (loss) recognized in OCI on derivative (effective portion)
	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
	(in thousands)
Interest rate swaps	$	11	$	(39)	$	(37)	$	(110)

The following table summarizes the reclassifications out of accumulated other comprehensive loss for the three and nine months ended September 30, 2016 and 2015:

Details about AOCI Components	Amount reclassified from AOCI into income (effective portion)								Location of amount
	Three Months Ended September 30,				Nine Months Ended September 30,				reclassified from AOCI
	2016		2015		2016		2015		into income (effective portion)
	(in thousands)
Interest rate swaps	$	8	$	22	$	31	$	72	Interest expense

As of September 30, 2016, $15,000 of deferred losses on derivative instruments accumulated in AOCI are expected to be reclassified to earnings during the next twelve months. Transactions and events expected to occur over the next twelve months that will necessitate reclassifying these derivatives’ losses to earnings include the repricing of variable-rate debt. There were no cash flow hedges discontinued during 2016 or 2015.

- Definition

The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Fair Value Measurements

9 Months Ended

Sep. 30, 2016

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

16. Fair Value Measurements

Fair value measurement is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. A fair value hierarchy is established, which prioritizes the inputs used in measuring fair value into three broad levels as follows:

Level 1—Quoted prices in active markets for identical assets or liabilities.

Level 2—Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly.

Level 3—Unobservable inputs based on the Company’s own assumptions.

The following tables present the fair value hierarchy for those liabilities measured at fair value on a recurring basis:

	Fair Value as of September 30, 2016
(In thousands)		Level 1		Level 2		Level 3		Total
Liabilities:
Interest rate swap agreements	$	-	$	16	$	-	$	16


	Fair Value as of December 31, 2015
(In thousands)		Level 1		Level 2		Level 3		Total
Liabilities:
Interest rate swap agreements	$	-	$	10	$	-	$	10

The Company uses the market approach technique to value its financial liabilities. The Company’s financial liabilities carried at fair value include derivative instruments used to hedge the Company’s interest rate risks. The fair value of the Company’s interest rate swap agreements was based on LIBOR yield curves at the reporting date.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2016
Income Tax [Abstract]
Income Taxes Disclosure [Text Block]	17. Income Tax Income tax was an approximately $#VALUE! million expense and a $#VALUE! million benefit for the three months ended September 30, 2016 and 2015, respectively. The tax expense for the three months ended September 30, 2016 reflects the incremental expense recorded for the nine months ended September 30, 2016 associated with the actual results for the nine-month period, as described below. As disclosed in footnote 5, during the three months ended September 30, 2016, the Company initiated a plan to sell its German subsidiary, AHN Biotechnologie GmbH. As a result, the Company determined that it was more likely than not that the deferred tax assets at AHN would not be realized and therefore recorded a valuation allowance of $0.6 million to offset deferred tax assets net of deferred tax liabilities. The decision was based on all available evidence, including but not limited to the determination that previous tax planning strategies would no longer be feasible. Discrete items included in the tax expense for the three months ended September 30, 2016 included the recording of a full valuation allowance against the net deferred tax assets of AHN, as well as the impact of an enacted tax rate change on the net deferred tax assets of one of the Company’s UK subsidiaries. Tax benefit for the three months ended September 30, 2015 included non-deductible acquisition costs and a return to provision adjustment. Income tax was an approximately $#VALUE! million expense and $#VALUE! million benefit for the nine months ended September 30, 2016 and 2015, respectively. The effective income tax rate was #VALUE! for the nine months ended September 30, 2016, compared with 42.3% for the same period in 2015. The tax rates for the nine months ended September 30, 2016 and 2015 were based on actual results for the nine-month period rather than an effective tax rate estimated for the entire year. The Company determined that using a year-to-date approach resulted in a better estimate of income tax expense based on its forecast of pre-tax income, the mix of income across several jurisdictions with different statutory tax rates, and the impact of the full valuation allowance against U.S. deferred tax assets. The difference between the Company’s effective tax rate period over period was primarily attributable to the mix of earnings between its domestic and foreign businesses, the impact of the full valuation allowance against U.S deferred tax assets recorded as of December 31, 2015, and the impact of a full valuation allowance against the deferred tax assets of one of the Company’s German subsidiaries recorded during the nine months ended September 30, 2016. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to classify deferred taxes between current and noncurrent. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted at the beginning of an interim or annual period. During the nine months ended September 30, 2016, the Company early adopted the new guidance on a prospective basis and has presented all deferred tax assets and deferred tax liabilities as noncurrent in the consolidated balance sheet at September 30, 2016. Prior periods presented in the consolidated financial statements were not retrospectively adjusted.

Subsequent Event

9 Months Ended

Sep. 30, 2016

Subsequent Events [Abstract]

Subsequent Event

18. Subsequent Events

On October 26, 2016, the Company sold the operations of AHN, a manufacturer of liquid handling products, located in Nordhausen, Germany, for $1.7 million. The results of operations and financial position of AHN have been reported in the Company’s consolidated statements of operations and balance sheet as of and for the three and nine months ended September 30, 2016. In addition to the impairment loss recorded on the long-lived assets of AHN in the Company’s consolidated statement of operations for the nine months ended September 30, 2016, the Company expects to record a loss on sale in the range of approximately $0.8 million to $1.0 million within operating expenses in the fourth quarter of 2016, due to the allocation of goodwill and transaction costs associated with the sale. As of September 30, 2016, the major classes of assets and liabilities of AHN, which were reported in the Company’s consolidated balance sheet, were comprised of the following:

		(in thousands)
Assets
Accounts receivable, net	$	349
Inventory		439
Property, plant and equipment, net		954
Amortizable intangible assets, net		205

Liabilities
Accounts payable and accrued expenses	$	198

Summary of Significant Accounting Policies (Policies)	9 Months Ended
Summary of Significant Accounting Policies (Policies)	Sep. 30, 2016
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements Disclosure [Text Block]	2. Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers,” a new accounting standard that provides for a comprehensive model to use in the accounting for revenue arising from contracts with customers that will replace most existing revenue recognition guidance within generally accepted accounting principles in the United States. Under this standard, revenue will be recognized to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. At its July 2015 meeting, the FASB agreed to defer the mandatory effective date of ASU 2014-09 one year. Under the one year deferral, the standard will take effect in 2018 for calendar year-end public entities. In July 2015, the FASB issued ASU 2015-11, Simplifying Measurement of Inventory. The update requires measurement of most inventory “at the lower of cost and net realizable value”, and applies to all entities that recognize inventory within the scope of ASC 330, except for inventory measured under the last-in, first-out (LIFO) method or the retail inventory method (RIM). ASU 2015-11 requires prospective application and represents a change in accounting principle. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. In February 2016, the FASB issued ASU 2016-02, Leases, which is intended to improve financial reporting about leasing transactions. The update requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. The update is effective for fiscal years beginning after December 15, 2018. In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which simplifies the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The update is effective for fiscal years beginning after December 15, 2016 and early adoption is permitted. In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326), Measurement of credit losses on Financial Instruments. The update amends the FASB’s guidance on the impairment of financial instruments. The ASU adds to U.S. GAAP an impairment model (known as the current expected credit loss (CECL) model) that is based on expected losses rather than incurred losses. Under the new guidance, an entity recognizes as an allowance its estimate of expected credit losses, which the FASB believes will result in more timely recognition of such losses. The ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (Topic 230) which amends ASC 230,Statement of Cash Flows to add or clarify guidance on the classification of certain cash receipts and payments in the statement of cash flows. The guidance is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company is evaluating the impact of each of ASU 2014-09, ASU 2015-11, ASU 2016-02, ASU 2016-09, ASU 2016-13 and ASU 2016-15 on its consolidated financial statements. Recently Adopted Accounting Pronouncements In April 2015, the FASB issued ASU 2015-03, Interest - Imputation of Interest - Simplifying the Presentation of Debt Issuance Costs. Under this guidance, debt issuance costs related to a recognized debt liability should be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. The provisions of this guidance are to be applied retrospectively and are effective for interim and annual periods beginning after December 15, 2015. The Company adopted this guidance during the nine months ended September 30, 2016. The consolidated balance sheet as of December 31, 2015, included in these consolidated financial statements, reflects a restatement to reclassify unamortized deferred financing costs of approximately $0.2 million from other long-term assets to long-term debt. For deferred financing costs paid to secure long-term debt, the Company made a policy election to present such costs as a direct deduction from the debt liability on the consolidated balance sheet. In September 2015, the FASB issued ASU 2015-16, Simplifying the Accounting for Measurement-Period Adjustments. The update eliminates the requirement to retrospectively adjust financial statements for measurement-period adjustments that occur in periods after a business combination. Under the update, measurement-period adjustments are to be calculated as if they were known at the acquisition date, but are recognized in the reporting period in which they are determined. Additional disclosures are required about the impact on current-period earnings. ASU 2015-16 requires prospective application to adjustments of provisional amounts that occur after the effective date. The update was effective for fiscal years beginning after December 15, 2015. The Company adopted ASU 2015-16 on January 1, 2016. The adoption of ASU 2015-16 did not have a material impact on its consolidated financial statements. In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. The update requires all deferred income taxes to be presented on the balance sheet as noncurrent. The new guidance is intended to simplify financial reporting by eliminating the requirement to classify deferred taxes between current and noncurrent. The update is effective for fiscal years beginning after December 15, 2016. Early adoption is permitted at the beginning of an interim or annual period. During the nine months ended September 30, 2016, the Company early adopted the new guidance on a prospective basis and has presented all deferred tax assets and deferred tax liabilities as noncurrent in the consolidated balance sheet at September 30, 2016.

Accumulated Other Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2016

Accumulated Other Comprehensive Income [Abstract]

Accumulated Other Comprehensive Income [Table Text Block]

		Foreign currency		Derivatives
		translation		qualifying as		Defined benefit
(in thousands)		adjustments		hedges		pension plans		Total

Balance at December 31, 2015	$	(9,594)	$	(10)	$	(2,280)	$	(11,884)

Other comprehensive loss before reclassifications		(1,390)		(37)		-		(1,427)
Amounts reclassified from AOCI		-		31		-		31

Other comprehensive loss		(1,390)		(6)		-		(1,396)

Balance at September 30, 2016	$	(10,984)	$	(16)	$	(2,280)	$	(13,280)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

Details about AOCI Components	Amount reclassified from AOCI into income (effective portion)								Location of amount
	Three Months Ended September 30,				Nine Months Ended September 30,				reclassified from AOCI
	2016		2015		2016		2015		into income (effective portion)
	(in thousands)
Interest rate swaps	$	8	$	22	$	31	$	72	Interest expense

Acquisitions (Tables)

9 Months Ended

Sep. 30, 2016

Acquisition Disclosure [Abstract]

Schedule of Business Acquisitions [Table Text Block]

		(in thousands)
Tangible assets	$	4,165
Liabilities assumed		(2,426)
Net assets		1,739

Goodwill and intangible assets:
Goodwill		1,668
Trade name		774
Customer relationships		1,627
Developed technology		1,338
Non-compete agreements		27
Deferred tax liabilities		(1,245)
Total goodwill and intangible assets, net of tax		4,189
Acquisition purchase price	$	5,928

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2016

Goodwill And Other Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill [Table Text Block]

									Weighted
									Average
		September 30, 2016				December 31, 2015			Life	(a)
		(in thousands)
Amortizable intangible assets:		Gross		Accumulated Amortization		Gross		Accumulated Amortization
Existing technology	$	15,687	$	(11,962)	$	16,022	$	(11,686)	7.1	Years
Trade names		7,623		(3,440)		7,636		(3,076)	8.2	Years
Distribution agreements/customer relationships		23,653		(12,800)		23,676		(11,849)	9.1	Years
Patents		216		(116)		245		(96)	2.4	Years
Total amortizable intangible assets		47,179	$	(28,318)		47,579	$	(26,707)

Indefinite-lived intangible assets:
Goodwill		39,624				40,357
Other indefinite-lived intangible assets		1,227				1,223
Total goodwill and other indefinite-lived intangible assets		40,851				41,580

Total intangible assets, gross	$	88,030			$	89,159

(a) Weighted average life as of September 30, 2016.

Goodwill Rollforward [Table Text Block]

Inventories (Tables)

9 Months Ended

Sep. 30, 2016

Inventories Disclosure [Abstract]

Schedule of Inventory [Table Text Block]

			September 30,		December 31,
			2016		2015
			(in thousands)
Finished goods		$	9,465	$	10,957
Work in process			935		888
Raw materials			10,831		10,498
	Total	$	21,231	$	22,343

Property, Plant and Equipment (Tables)

9 Months Ended

Sep. 30, 2016

Property, Plant and Equipment Disclosure [Abstract]

Schedule Of Property Plant And Equipment [Table Text Block]

		September 30,		December 31,
		2016		2015
		(in thousands)
Land, buildings and leasehold improvements	$	2,594	$	2,825
Machinery and equipment		9,590		10,131
Computer equipment and software		7,989		7,503
Furniture and fixtures		1,590		1,358
Automobiles		221		103
		21,984		21,920
Less: accumulated depreciation		(16,717)		(16,018)
Property, plant and equipment, net	$	5,267	$	5,902

Restructuring and Other Exit Costs (Tables)

9 Months Ended

Sep. 30, 2016

Restructuring and Related Activities [Abstract]

Restructuring Plan Table [Table Text Block]


		Severance Costs		Other		Total
		(in thousands)
Restructuring balance at December 31, 2015	$	132	$	-	$	132
Restructuring charges		-		32		32
Non-cash reversal of restructuring charges		(27)		-		(27)
Cash payments		(101)		(28)		(129)
Effect of change in currency translation		(4)		(4)		(8)
Restructuring balance at September 30, 2016	$	-	$	-	$	-

		Severance Costs		Other		Total
		(in thousands)
Restructuring balance at December 31, 2014	$	626	$	-	$	626
Restructuring charges		227		339		566
Non-cash reversal of restructuring charges		(79)		-		(79)
Cash payments		(650)		(295)		(945)
Effect of change in currency translation		(8)		-		(8)
Restructuring balance at September 30, 2015	$	116	$	44	$	160

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015
		(in thousands)
Restructuring charges	$	(17)	$	376	$	(5)	$	487

Warranties (Tables)

9 Months Ended

Sep. 30, 2016

Warranties Disclosure [Abstract]

Warranty Rollforward Disclosure [Table Text Block]

		Beginning		Additions/		Ending
		Balance	Payments	(Credits)		Balance
		(in thousands)

Year ended December 31, 2015	$	252	(81)	(24)	$	147

Nine months ended September 30, 2016	$	147	(56)	94	$	185

Employee Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2016

Employee Benefit Plans Disclosure [Abstract]

Schedule of Changes in Projected Benefit Obligations [Table Text Block]

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015
		(in thousands)
Components of net periodic benefit cost:
Interest cost	$	156	$	175	$	492	$	542
Expected return on plan assets		(168)		(165)		(530)		(510)
Net amortization loss		74		75		233		231
Net periodic benefit cost	$	62	$	85	$	195	$	263

Leases (Tables)

9 Months Ended

Sep. 30, 2016

Leases Disclosure [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

		Operating
		Leases
		(in thousands)
2017	$	1,754
2018		1,754
2019		1,647
2020		1,423
2021		1,216
Thereafter		3,372
Net minimum lease payments	$	11,166

Capital Stock (Tables)

9 Months Ended

Sep. 30, 2016

Capital Stock Disclosure [Abstract]

Schedule Of Stock Options And Restricted Stock Units Activity Rollforward [Table Text Block]

		Stock Options			Restricted Stock Units			Market Condition RSU's
				Weighted
		Stock		Average	Restricted			Market
		Options		Exercise	Stock Units		Grant Date	Condition RSU's		Grant Date
		Outstanding		Price	Outstanding		Fair Value	Outstanding		Fair Value

Balance at December 31, 2015		5,022,186	$	3.85	313,559	$	5.29	185,538	$	4.81
	Granted	43,000		3.10	1,095,190		2.92	-		-
	Exercised	(374,772)		2.80	-		-	-		-
	Vested (RSUs)	-		-	(276,420)		-	-		-
	Cancelled / forfeited	(672,166)		3.87	(31,782)		3.87	(3,388)		4.81
Balance at September 30, 2016		4,018,248	$	3.97	1,100,547	$	3.15	182,150	$	4.81

Table Of Assumptions [Table Text Block]

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2016		2015		2016		2015
Volatility	43.05	%	39.47	%	41.97	%	41.07	%
Risk-free interest rate	1.01	%	1.76	%	1.29	%	1.72	%
Expected holding period (in years)	5.08	years	5.25	years	5.21	years	5.52	years
Dividend yield	-	%	-	%	-	%	-	%

Stock Based Compensation Expense Activity By Function [Table Text Block]

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015
		(in thousands)

Cost of revenues	$	17	$	18	$	44	$	54
Sales and marketing		159		149		401		343
General and administrative		736		583		2,071		1,580
Research and development		31		27		80		72
Total stock-based compensation	$	943	$	777	$	2,596	$	2,049

Basic and Diluted Shares [Table Text Block]

	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2016	2015	2016	2015

Basic	34,327,459	33,933,327	34,156,606	33,473,958
Effect of assumed conversion of employee and director stock options, restricted stock units and Market Condition RSU's	-	-	-	-
Diluted	34,327,459	33,933,327	34,156,606	33,473,958

Long Term Debt (Tables)

9 Months Ended

Sep. 30, 2016

Long Term Debt Disclosure [Abstract]

Schedule of Debt [Table Text Block]

		September 30,		December 31,
		2016		2015
		(in thousands)
Long-term debt:
Term loan	$	5,737	$	6,750
DDTL		4,675		5,500
Revolving line		4,750		6,650
Total unamortized deferred financing costs		(120)		(167)
Total debt		15,042		18,733
Less: current installments		(2,450)		(2,450)
Current unamortized deferred financing costs		76		86
Long-term debt	$	12,668	$	16,369

Derivative (Tables)

9 Months Ended

Sep. 30, 2016

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]


				September 30, 2016		September 30, 2016
				Notional Amount		Fair Value (a)
Derivatives designated as hedging instruments under ASC 815		Balance sheet classification		(in thousands)
Interest rate swaps		Other liabilities-non current	$	6,500	$	(16)


				December 31, 2015		December 31, 2015
				Notional Amount		Fair Value (a)
Derivatives designated as hedging instruments under ASC 815		Balance sheet classification		(in thousands)
Interest rate swaps		Other liabilities-non current	$	9,500	$	(10)

	(a) See Note 16 for the fair value measurements related to these financial instruments.

Schedule of Cash Flow Hedges Included in AOCI [Table Text Block]

Derivatives in Hedging Relationships	Amount of gain (loss) recognized in OCI on derivative (effective portion)
	Three Months Ended September 30,				Nine Months Ended September 30,
	2016		2015		2016		2015
	(in thousands)
Interest rate swaps	$	11	$	(39)	$	(37)	$	(110)

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

Details about AOCI Components	Amount reclassified from AOCI into income (effective portion)								Location of amount
	Three Months Ended September 30,				Nine Months Ended September 30,				reclassified from AOCI
	2016		2015		2016		2015		into income (effective portion)
	(in thousands)
Interest rate swaps	$	8	$	22	$	31	$	72	Interest expense

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2016

Fair Value Disclosures [Abstract]

Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis [Table Text Block]

	Fair Value as of September 30, 2016
(In thousands)		Level 1		Level 2		Level 3		Total
Liabilities:
Interest rate swap agreements	$	-	$	16	$	-	$	16


	Fair Value as of December 31, 2015
(In thousands)		Level 1		Level 2		Level 3		Total
Liabilities:
Interest rate swap agreements	$	-	$	10	$	-	$	10

Subsequent Events (Table)

9 Months Ended

Sep. 30, 2016

Subsequent Events [Abstract]

Schedule of Disposal Group's Balance Sheet

As of September 30, 2016, the major classes of assets and liabilities of AHN, which were reported in the Company’s consolidated balance sheet, were comprised of the following:

		(in thousands)
Assets
Accounts receivable, net	$	349
Inventory		439
Property, plant and equipment, net		954
Amortizable intangible assets, net		205

Liabilities
Accounts payable and accrued expenses	$	198

- Definition

Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721533-107759

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721665-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1474-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721683-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51719941&loc=SL51724579-110230

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721663-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2941-110230

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721659-107760

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721671-107760

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5D
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721677-107760

+ Details

Accumulated Other Comprehensive Income (Details)	9 Months Ended
Accumulated Other Comprehensive Income (Details)	Sep. 30, 2016 USD ($)
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	$ (11,884,000)
Other Comprehensive Income (Loss) before Reclassifications	(1,427,000)
Reclassification from Accumulated Other Comprehensive Income	31,000
Other Comprehensive Income (Loss), Net of Tax, total	(1,396,000)
Closing Balance	(13,280,000)
Foreign currency translation adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	(9,594,000)
Other Comprehensive Income (Loss) before Reclassifications	(1,390,000)
Reclassification from Accumulated Other Comprehensive Income	0
Other Comprehensive Income (Loss), Net of Tax, total	(1,390,000)
Closing Balance	(10,984,000)
Derivatives qualifying as hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	(10,000)
Other Comprehensive Income (Loss) before Reclassifications	(37,000)
Reclassification from Accumulated Other Comprehensive Income	31,000
Other Comprehensive Income (Loss), Net of Tax, total	(6,000)
Closing Balance	(16,000)
Defined benefit pension plans [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Opening Balance	(2,280,000)
Other Comprehensive Income (Loss) before Reclassifications	0
Reclassification from Accumulated Other Comprehensive Income	0
Other Comprehensive Income (Loss), Net of Tax, total	0
Closing Balance	$ (2,280,000)

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References + Details

Accumulated Other Comprehensive Income (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Reclassifications Out of Accumulated Other Comprehensive Income [Line Items]
Derivatives Reclassification Adjustment from AOCI, net tax	$ (8)	$ (22)	$ (31)	$ (72)
Reclassification from Accumulated Other Comprehensive Income			$ (31)

Acquisitions (Narratives) (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Business Acquisition [Line Items]
Business Acquisition Direct Acquisition Costs In Income Statement	$ 200		$ 900
Goodwill Other Changes		$ 50

Acquisitions (Details 1) - HEKA Elektronik [Member] $ in Thousands	Jan. 08, 2015 USD ($)
Business Acquisition [Line Items]
Tangible Assets Acquired	$ 4,165
Liabilities Assumed	(2,426)
Net Tangible Assets Acquired	1,739
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Goodwill Amount	1,668
Deferred Tax Liabilities	1,245
Business Acquisition Purchase Price Allocation Total Intangible Assets Amount Including Goodwill	4,189
Total Acquisition Purchase Price	5,928
Business Acquisition, Cost of Acquired Entity 1 [Abstract]
Business Acquisition Cost Of Acquired Entity Purchase Price 1	5,928
Unpatented Technology [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets	1,338
Customer Relationships [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets	1,627
Trade Names [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets	774
Non compete Agreements [Member]
Business Acquisition Purchase Price Allocation Intangible Assets [Abstract]
Purchase Price Allocation, Amortizable Intangible Assets	$ 27

Goodwill and Other Intangible Assets (Narratives) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Goodwill And Other Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 729	$ 666	$ 2,099	$ 2,137
Estimated Amortization Expense Next Twelve Months	2,600		2,600
Estimated Amortization Expense Year 2	2,500		2,500
Estimated Amortization Expense Year 3	2,300		2,300
Estimated Amortization Expense Year 4	2,200		2,200
Estimated Amortization Expense Year 5	2,100		2,100
Finite-lived intangible assets
Impairment charges	676	$ 0	676	$ 0
Trade name and customer relationships
Finite-lived intangible assets
Impairment charges	$ 100		$ 100

Goodwill and Other Intangible Assets (Details 1) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 47,179	$ 47,579
Finite-Lived Intangible Assets, Accumulated Amortization	(28,318)	(26,707)
Goodwill	39,624	40,357
Other indefinite lived intangible assets	1,227	1,223
Total goodwill and other indefinite lived intangible assets	40,851	41,580
Total intangible assets	88,030	89,159
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	15,687	16,022
Finite-Lived Intangible Assets, Accumulated Amortization	$ (11,962)	(11,686)
Finite-Lived Intangible Assets, Weighted Average Useful Life	7 years 1 month
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 7,623	7,636
Finite-Lived Intangible Assets, Accumulated Amortization	$ (3,440)	(3,076)
Finite-Lived Intangible Assets, Weighted Average Useful Life	8 years 2 months
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 23,653	23,676
Finite-Lived Intangible Assets, Accumulated Amortization	$ (12,800)	(11,849)
Finite-Lived Intangible Assets, Weighted Average Useful Life	9 years 1 month
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 216	245
Finite-Lived Intangible Assets, Accumulated Amortization	$ (116)	$ (96)
Finite-Lived Intangible Assets, Weighted Average Useful Life	2 years 5 months

Goodwill and Other Intangible Assets (Details 2) $ in Thousands	9 Months Ended
	Sep. 30, 2016 USD ($)
Goodwill And Other Intangible Assets Disclosure [Abstract]
Goodwill, Beginning Balance	$ 40,357
Goodwill Other Changes	50
Foreign currency translation adjustments related to goodwill balance	(783)
Goodwill, Ending Balance	$ 39,624

Inventories (Details 1) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Inventories Disclosure [Abstract]
Finished Goods	$ 9,465	$ 10,957
Work in Process	935	888
Raw Materials	10,831	10,498
Total Inventories, Net	$ 21,231	$ 22,343

Property, Plant and Equipment (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 21,984		$ 21,984		$ 21,920
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(16,717)		(16,717)		(16,018)
Property, plant and equipment, net	5,267		5,267		5,902
Impairment charges	676	$ 0	676	$ 0
Land, Buildings and Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	2,594		2,594		2,825
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	9,590		9,590		10,131
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	7,989		7,989		7,503
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	1,590		1,590		1,358
Automobiles [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	221		221		$ 103
Property, Plant and Equipment
Property, Plant and Equipment [Line Items]
Impairment charges	$ 600		$ 600

Restructuring and Other Exit Cots (Narratives) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring charges (credits)	$ (17)	$ 376	$ (5)	$ 487

Restructuring and Other Exit Costs (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Restructuring Reserve [Roll Forward]
Restructuring charges (credits)	$ (17)	$ 376	$ (5)	$ 487
Restructuring Plan 2016 Consolidated [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance			132
Restructuring charges (credits)			32
Restructuring Reserve, Settled with Cash			(129)
Restructuring Reserve, Accrual Adjustment			(27)
Restructuring Reserve, Translation Adjustment			(8)
Restructuring Reserve, Ending Balance	0		0
Restructuring Plan 2015 Consolidated [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance				626
Restructuring charges (credits)				566
Restructuring Reserve, Settled with Cash				(945)
Restructuring Reserve, Accrual Adjustment				(79)
Restructuring Reserve, Translation Adjustment				(8)
Restructuring Reserve, Ending Balance		160		160
Employee Severance [Member] \| Restructuring Plan 2016 Consolidated [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance			132
Restructuring charges (credits)			0
Restructuring Reserve, Settled with Cash			(101)
Restructuring Reserve, Accrual Adjustment			(27)
Restructuring Reserve, Translation Adjustment			(4)
Restructuring Reserve, Ending Balance	0		0
Employee Severance [Member] \| Restructuring Plan 2015 Consolidated [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance				626
Restructuring charges (credits)				227
Restructuring Reserve, Settled with Cash				(650)
Restructuring Reserve, Accrual Adjustment				(79)
Restructuring Reserve, Translation Adjustment				(8)
Restructuring Reserve, Ending Balance		116		116
Other Costs [Member] \| Restructuring Plan 2016 Consolidated [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance			0
Restructuring charges (credits)			32
Restructuring Reserve, Settled with Cash			(28)
Restructuring Reserve, Accrual Adjustment			0
Restructuring Reserve, Translation Adjustment			(4)
Restructuring Reserve, Ending Balance	$ 0		$ 0
Other Costs [Member] \| Restructuring Plan 2015 Consolidated [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance				0
Restructuring charges (credits)				339
Restructuring Reserve, Settled with Cash				(295)
Restructuring Reserve, Accrual Adjustment				0
Restructuring Reserve, Translation Adjustment				0
Restructuring Reserve, Ending Balance		$ 44		$ 44

Related Party Transactions (Narratives) (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Business Acquisition [Line Items]
Operating Leases, Rent Expense, Net	$ 500,000	$ 600,000	$ 1,400,000	$ 1,800,000
Multi Channel Systems MCS GmbH [Member]
Business Acquisition [Line Items]
Operating Leases, Rent Expense, Net	59,000	59,000	172,000	172,000
Triangle BioSystems, Inc. [Member]
Business Acquisition [Line Items]
Operating Leases, Rent Expense, Net	$ 11,000	$ 11,000	$ 32,000	$ 32,000

Warranties (Details 1) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
Warranties (Details 1) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Product Warranty Disclosure [Abstract]
Warranty, Beginning Balance	$ 147	$ 252
Warranty payments	(56)	(81)
Warranty additions	94	(24)
Warranty, Ending Balance	$ 185	$ 147

Employee Benefit Plans (Narratives) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Employee Benefit Plans Disclosure [Abstract]
Expected employer contribution in current remaining fiscal year	$ 300		$ 300
Defined Benefit Plan Payments In Current Fiscal Year	200	$ 200	500	$ 600
Defined Benefit Plans Liabilities Noncurrent	2,600		$ 2,600		$ 2,800
Unrealized losses on pension benefit obligation, net of tax	$ 0	$ 0

Employee Benefit Plans (Details 1) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Employee Benefit Plans (Details 1) - USD ($) $ in Thousands	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Employee Benefit Plans Disclosure [Abstract]
Interest Cost	$ 156	$ 175	$ 492	$ 542
Expected Return on Plan Assets	(168)	(165)	(530)	(510)
Net Amortization Loss	74	75	233	231
Curtailment Gain				0
Net Periodic Benefit Cost, Total	62	85	195	263
Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]
Interest Cost	156	175	492	542
Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]
Defined Benefit Plan Payments In Current Fiscal Year	$ 200	$ 200	$ 500	$ 600

Leases (Narratives) (Details) - USD ($)	3 Months Ended		9 Months Ended
Leases (Narratives) (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Leases Disclosure [Abstract]
Estimated Rental Expenses Current Year			$ 1,900,000
Operating Leases, Rent Expense, Net	$ 500,000	$ 600,000	$ 1,400,000	$ 1,800,000

Leases (Details 1) $ in Thousands	Sep. 30, 2016 USD ($)
Leases Disclosure [Abstract]
2016	$ 1,754
2017	1,754
2018	1,647
2019	1,423
2020	1,216
Thereafter	3,372
Operating Leases, Total Future Minimum Payments Due	$ 11,166

Capital Stock (Narratives) (Details) - $ / shares	3 Months Ended		9 Months Ended
Capital Stock (Narratives) (Details) - $ / shares	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Apr. 03, 2015
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date			85.00%
Employee Stock Purchase Plan Shares Authorized	750,000		750,000
Stock issued during the year, Shares, Employee Stock Purchase Plans	39,353	26,181	683,364
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized						17,508,929
Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan						2,500,000
Equity Instruments Other than Options, Grants in Period			1,095,190
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	5,300,945	5,640,536	5,300,945	5,640,536
Percentage Of Outstanding Common Stock	20.00%		20.00%
Weighted Average Estimated Black Scholes Value Of Option Grants	$ 1.11	$ 2.14	$ 1.21	$ 2.21
Preferred Stock - Shares Authorized	5,000,000		5,000,000		5,000,000
Market Condition Restricted Stock Unit [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Equity Instruments Other than Options, Grants in Period			0

Capital Stock (Details 1) - $ / shares	3 Months Ended		9 Months Ended
Capital Stock (Details 1) - $ / shares	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Apr. 03, 2015
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Opening Balance Stock Options Outstanding			5,022,186
Begining Balance Weighted Average Exercise Price			$ 3,850
Increase In Number Of Shares Authorized For Issuance Under Stock Option And Incentive Plan						2,500,000
Options, Grants in Period, Gross			43,000
Stock option exercises during the year, Shares			374,772
Options, Forfeitures and Expirations in Period			672,166
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price			$ 3.87
Closing Balance Stock Options Outstanding	4,018,248		4,018,248
Closing Balance Weighted Average Exercise Price	$ 3.97		$ 3.97
Begining Balance Restricted Stock Units Outstanding			313,559
Equity Instruments Other than Options, Grants in Period			1,095,190
Equity Instruments Other than Options, Vested in Period			276,420
Closing Balance Restricted Stock Units Outstanding	1,100,547		1,100,547
Begining Balance Grant Date Fair Value Of Restricted Stock Units			$ 5.29
Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			2.92
Closing Balance Grant Date Fair Value Of Restricted Stock Units	$ 3.15		$ 3.15
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Expected Volatility Rate	43.05%	39.47%	41.97%	41.07%
Fair Value Assumptions, Risk Free Interest Rate	1.01%	1.76%	1.29%	1.72%
Fair Value Assumptions, Expected Term	5 years 1 month 28 days	5 years 3 months 10 days	5 years 3 months 7 days	5 years 6 months 7 days
Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%	0.00%	0.00%
Options, Exercises in Period, Weighted Average Exercise Price			$ 2.8
Options, Grants in Period, Weighted Average Exercise Price			3.1
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value			$ 3.87
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			31,782
Preferred Stock - Shares Authorized	5,000,000		5,000,000		5,000,000
Market Condition Restricted Stock Unit [Member]
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Begining Balance Restricted Stock Units Outstanding			185,538
Equity Instruments Other than Options, Grants in Period			0
Equity Instruments Other than Options, Vested in Period			0
Closing Balance Restricted Stock Units Outstanding	182,150		182,150
Begining Balance Grant Date Fair Value Of Restricted Stock Units			$ 4.81
Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value			0
Closing Balance Grant Date Fair Value Of Restricted Stock Units	$ 4.81		4.81
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Fair Value Assumptions, Expected Volatility Rate		35.88%
Fair Value Assumptions, Risk Free Interest Rate		0.99%
Fair Value Assumptions, Expected Dividend Rate		0.00%
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Correlation Coefficient		0.25%
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period, Weighted Average Grant Date Fair Value			$ 4.81
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			3,388

Capital Stock (Details 2) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Capital Stock (Details 2) - USD ($) $ in Thousands	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	$ 943	$ 777	$ 2,596	$ 2,049
Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]
Basic	34,327,459	33,933,327	34,156,606	33,473,958
Weighted Average Number Diluted Shares Outstanding Adjustment	0	0	0	0
Diluted	34,327,459	33,933,327	34,156,606	33,473,958
Cost of Sales [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	$ 17	$ 18	$ 44	$ 54
Research and Development Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	31	27	80	72
Selling and Marketing Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	159	149	401	343
General and Administrative Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation	$ 736	$ 583	$ 2,071	$ 1,580

Capital Stock (Details 3) - shares	Sep. 30, 2016	Dec. 31, 2015
Share-Based Compensation Arrangement By Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	4,018,248	5,022,186

Long Term Debt (Narratives) (Details) - USD ($) $ in Thousands					3 Months Ended	9 Months Ended
	Apr. 24, 2015	Oct. 31, 2013	Mar. 29, 2013	Aug. 07, 2009	Sep. 30, 2016	Sep. 30, 2016	Dec. 31, 2015
Credit Agreement [Line Items]
Previous Approved Credit Facility				$ 20,000
Secured Debt					$ 15,042	$ 15,042	$ 18,733
Line of Credit Facility, Maximum Borrowing Capacity			$ 50,000
Minimum percentage of Term Loan and the DDTL that company was required to fix the rate of interest on					50.00%	50.00%
Line of Credit Facility, Remaining Borrowing Capacity					$ 7,800	$ 7,800
Interest Rate In Excess Of LIBOR On Credit Facility				3.00%
DDTL Threshold For Dollar For Dollar Reduction In Revolving Line			10,000
Transfer Of Delayed Draw Down Term Loan Capacity To Revolver Capacity		$ 5,000
Lender Approval To Fund Acquisition With Cash Promissory Note In Excess Of Threshold					6,000	6,000
Lender Approval To Fund Acquisition With Equity In Excess Of Threshold					10,000	10,000
Revolving Credit Facility [Member]
Credit Agreement [Line Items]
Secured Debt			$ 25,000		$ 4,750	$ 4,750	6,650
Maturity Dates			Mar. 29, 2018
Basis Spread Over LIBOR	2.25%
Interest Rate As Of Reporting Date					2.77%	2.77%
Term Loan [Member]
Credit Agreement [Line Items]
Secured Debt			$ 15,000		$ 5,737	$ 5,737	6,750
Maturity Dates			Mar. 29, 2018
Basis Spread Over LIBOR	2.50%
Interest Rate As Of Reporting Date					3.96%	3.96%
Delayed Drawdown Term Loan [Member]
Credit Agreement [Line Items]
Secured Debt			$ 15,000		$ 4,675	$ 4,675	$ 5,500
Maturity Dates			Mar. 29, 2018
Basis Spread Over LIBOR	2.50%
Maximum Borrowings Available Under The Current Credit Agreement		$ 10,000
Interest Rate As Of Reporting Date					3.60%	3.60%

Long Term Debt (Details 1) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015	Mar. 29, 2013
Debt Instrument [Line Items]
Secured Debt	$ 15,042	$ 18,733
Unamortized Debt Issuance Expense	(120)	(167)
Current portion, long-term debt	(2,374)	(2,364)
Long-term debt	12,668	16,369
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Secured Debt	4,750	6,650	$ 25,000
Term Loan [Member]
Debt Instrument [Line Items]
Secured Debt	5,737	6,750	15,000
Delayed Drawdown Term Loan [Member]
Debt Instrument [Line Items]
Secured Debt	$ 4,675	$ 5,500	$ 15,000

Derivative (Narratives) (Details) - USD ($)	3 Months Ended	9 Months Ended
Derivative (Narratives) (Details) - USD ($)	Sep. 30, 2016	Sep. 30, 2016	Nov. 30, 2013	Jun. 05, 2013
Derivative Instruments And Hedging Activities Disclosure [Line Items]
Minimum percentage of Term Loan and the DDTL that company was required to fix the rate of interest on	50.00%	50.00%
Deferred losses on derivative instruments accumulated in AOCI expected to be reclassified to earnings		$ 15,000
Derivative Interest Rate Swap Effective Percentage		100.00%
Delayed Drawdown Term Loan [Member]
Derivative Instruments And Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Swaps			$ 5,000,000
LIBOR Fixed Rate		0.93%
Term Loan [Member]
Derivative Instruments And Hedging Activities Disclosure [Line Items]
Notional Amount of Interest Rate Swaps				$ 15,000,000
LIBOR Fixed Rate		0.96%

Derivative (Details 1) - Other liabilities-non current [Member] - Derivatives qualifying as hedges [Member] - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Derivatives, Fair Value [Line Items]
Notional Amount of Interest Rate Derivatives	$ 6,500	$ 9,500
Derivative Liability, Fair Value, Net	$ (16)	$ (10)

Derivative (Details 2) - Derivatives qualifying as hedges [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Loss Recognized in Other Comprehensive Income (Loss), Effective Portion	$ 11	$ (39)	$ (37)	$ (110)
Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion	$ 8	$ 22	$ 31	$ 72

Fair Value Measurements (Details) - Derivatives qualifying as hedges [Member] - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Inputs, Level 1 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative Liabilities	$ 0	$ 0
Fair Value, Inputs, Level 2 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative Liabilities	16	10
Fair Value, Inputs, Level 3 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivative Liabilities	$ 0	$ 0

Income Tax (Narratives) (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
Income Tax (Narratives) (Details) - USD ($) $ in Millions	Sep. 30, 2016	Sep. 30, 2016	Sep. 30, 2015
Income Tax [Abstract]
Effective Income Tax Rate		42.90%	42.30%
Change In Valuation Allowances For Deferred Tax Assets	$ 0.6	$ 0.6

Subsequent Events (Details 1) - Subsequent Event - USD ($) $ in Millions		3 Months Ended
	Oct. 26, 2016	Dec. 31, 2016
Minimum
Subsequent Event
Loss on sale of business		$ (0.8)
Maximum
Subsequent Event
Loss on sale of business		$ (1.0)
AHN
Subsequent Event
Cash proceeds from sale of business	$ 1.7

Subsequent Events (Details 2) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014
Assets
Cash and cash equivalents	$ 5,345	$ 6,744	$ 6,090	$ 6,090	$ 14,134
Accounts receivable, net of allowance for doubtful accounts of $386 and $310, respectively	15,115	17,547
Inventories	21,231	22,343
Property, plant and equipment, net	5,267	5,902
Amortizable intangible assets, net	18,861	20,872
Goodwill	39,624	40,357
Current liabilities:
Accrued expenses	4,501	4,021
Accounts payable	6,142	$ 8,782
AHN
Assets
Accounts receivable, net of allowance for doubtful accounts of $386 and $310, respectively	349
Inventories	439
Property, plant and equipment, net	954
Amortizable intangible assets, net	205
Current liabilities:
Accrued expenses	$ 198